Contribution of rare genetic variants to drug response in absence epilepsy
Tài liệu tham khảo
Badawy, 2009, Cortical hyperexcitability and epileptogenesis: Understanding the mechanisms of epilepsy - part 2, J. Clin. Neurosci., 16, 485, 10.1016/j.jocn.2008.10.001
Balestrini, 2018, Pharmacogenomics in epilepsy, Neurosci. Lett., 667, 27, 10.1016/j.neulet.2017.01.014
Berkovic, 1998, Epilepsies in twins: genetics of the major epilepsy syndromes, Ann. Neurol., 43, 435, 10.1002/ana.410430405
Bomben, 2016, Isolated P/Q calcium channel deletion in layer VI corticothalamic neurons generates absence epilepsy, J. Neurosci., 36, 405, 10.1523/JNEUROSCI.2555-15.2016
Bruni, 1979, Valproic acid. Review of a new antiepileptic drug, Arch. Neurol., 36, 393, 10.1001/archneur.1979.00500430023002
Chen, 2003, Association between genetic variation of CACNA1H and childhood absence epilepsy, Ann. Neurol., 54, 239, 10.1002/ana.10607
Coulter, 1989, Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons, Ann. Neurol., 25, 582, 10.1002/ana.410250610
Epi4K consortium, Epilepsy Phenome/Genome Project, 2017, Ultra-rare genetic variation in common epilepsies: a case-control sequencing study, Lancet Neurol., 16, 135, 10.1016/S1474-4422(16)30359-3
Gambardella, 2017, Role of pharmacogenomics in antiepileptic drug therapy: current status and future perspectives, Curr. Pharm. Des., 23, 5760, 10.2174/1381612823666170911111536
Glauser, 2010, Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy, N. Engl. J. Med., 362, 790, 10.1056/NEJMoa0902014
Glauser, 2013, Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months, Epilepsia, 54, 141, 10.1111/epi.12028
Glauser, 2017, Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy, Ann. Neurol., 81, 444, 10.1002/ana.24886
Gloor, 1988, Generalized epilepsy: some of its cellular mechanisms differ from those of focal epilepsy, Trends Neurosci., 11, 63, 10.1016/0166-2236(88)90166-X
Heron, 2007, Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants, Ann. Neurol., 62, 560, 10.1002/ana.21169
Huguenard, 1994, Intrathalamic rhythmicity studied in vitro: nominal T-current modulation causes robust antioscillatory effects, J. Neurosci., 14, 5485, 10.1523/JNEUROSCI.14-09-05485.1994
Imbrici, 2004, Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia, Brain, 127, 2682, 10.1093/brain/awh301
Jallon, 2005, Epidemiology of idiopathic generalized epilepsies, Epilepsia, 46, 10, 10.1111/j.1528-1167.2005.00309.x
Jouvenceau, 2001, Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel, Lancet, 358, 801, 10.1016/S0140-6736(01)05971-2
Lek, 2016, Analysis of protein-coding genetic variation in 60,706 humans, Nature, 536, 285, 10.1038/nature19057
Li, 2009, Fast and accurate short read alignment with Burrows-Wheeler transform, Bioinformatics, 25, 1754, 10.1093/bioinformatics/btp324
Marini, 2004, Genetic architecture of idiopathic generalized epilepsy: clinical genetic analysis of 55 multiplex families, Epilepsia, 45, 467, 10.1111/j.0013-9580.2004.46803.x
May, 2018, Rare coding variants in genes encoding GABAA receptors in genetic generalised epilepsies: an exome-based case-control study, Lancet Neurol., 17, 699, 10.1016/S1474-4422(18)30215-1
Mullen, 2010, Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency, Neurology, 75, 432, 10.1212/WNL.0b013e3181eb58b4
Noai, 2016, Cytochrome P450 2C19 polymorphisms and valproic acid-induced weight gain, Acta Neurol. Scand., 133, 216, 10.1111/ane.12473
Pedersen, 2016, Vcfanno: fast, flexible annotation of genetic variants, Genome Biol., 17, 118, 10.1186/s13059-016-0973-5
Sadleir, 2006, Electroclinical features of absence seizures in childhood absence epilepsy, Neurology, 67, 413, 10.1212/01.wnl.0000228257.60184.82
Sills, 2020, Mechanisms of action of currently used antiseizure drugs, Neuropharmacology, 168, 10.1016/j.neuropharm.2020.107966
Van der Auwera, 2013, From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline, Curr. Protoc. Bioinformatics, 43, 10.1002/0471250953.bi1110s43
Wallace, 2001, Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures, Nat. Genet., 28, 49, 10.1038/ng0501-49
Wang, 2010, ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data, Nucleic Acids Res., 38, e164, 10.1093/nar/gkq603